GeezerVison is showing www.rcsb.org — RCSB PDB - 4AF3: Human Aurora B Kinase in complex with INCENP and VX-680 4AF3 | pdb_00004af3Human Aurora B Kinase in complex with INCENP and VX-680 - Classification: TRANSFERASE/INHIBITOR
- Organism(s): Homo sapiens
- Expression System: Escherichia coli BL21(DE3)
- Mutation(s): Yes
- Deposited: 2012-01-16 Released: 2012-04-11
- Deposition Author(s): Elkins, J.M., Vollmar, M., Wang, J., Picaud, S., Arrowsmith, C.H., Edwards, A., Bountra, C., von Delft, F., Knapp, S.
Experimental Data Snapshot - Method: X-RAY DIFFRACTION
- Resolution: 2.75 Å
- R-Value Free:
0.264 (Depositor), 0.272 (DCC) - R-Value Work:
0.205 (Depositor), 0.207 (DCC) - R-Value Observed:
0.208 (Depositor)
Starting Model: experimental View more details This is version 1.3 of the entry. See complete history. Crystal Structure of Human Aurora B in Complex with Incenp and Vx-680.Elkins, J.M., Santaguida, S., Musacchio, A., Knapp, S.(2012) J Med Chem 55: 7841 - PubMed: 22920039 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1021/jm3008954
- Primary Citation Related Structures:
4AF3
- PubMed Abstract:
We present the structure of the human Aurora B kinase domain in complex with the C-terminal Aurora-binding region of human INCENP and the Aurora kinase inhibitor VX-680. The structure unexpectedly reveals a dimeric arrangement of the Aurora B:INCENP complex, which was confirmed to exist in solution by analytical ultracentrifugation. The dimerization involves a domain swap of the activation loop, resulting in a different conformation of the DFG motif as compared to that seen in other kinase complexes with VX-680. The binding of INCENP differs significantly from that seen in the Xenopus laevis Aurora B:INCENP complex currently used as a model for structure-based design for this important oncology target. Organizational Affiliation: - Nuffield Department of Clinical Medicine, Structural Genomics Consortium, University of Oxford , Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, United Kingdom. [email protected]
Macromolecule Content - Total Structure Weight: 42.4 kDa
- Atom Count: 2,427
- Modeled Residue Count: 296
- Deposited Residue Count: 363
- Unique protein chains: 2
Small Molecules| Ligands 1 Unique |
|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions |
|---|
VX6
Query on VX6
Download:Ideal Coordinates CCD File
| C [auth A] | CYCLOPROPANECARBOXYLIC ACID {4-[4-(4-METHYL-PIPERAZIN-1-YL)-6-(5-METHYL-2H-PYRAZOL-3-YLAMINO)-PYRIMIDIN-2-YLSULFANYL]-PHENYL}-AMIDE C23 H28 N8 O S GCIKSSRWRFVXBI-UHFFFAOYSA-N |  | |
Experimental Data & ValidationExperimental Data- Method: X-RAY DIFFRACTION
- Resolution: 2.75 Å
- R-Value Free: 0.264 (Depositor), 0.272 (DCC)
- R-Value Work: 0.205 (Depositor), 0.207 (DCC)
- R-Value Observed: 0.208 (Depositor)
Unit Cell: | Length ( Å ) | Angle ( ˚ ) |
|---|
| a = 80.145 | α = 90 | | b = 80.145 | β = 90 | | c = 92.542 | γ = 120 |
Software Package:| Software Name | Purpose |
|---|
| REFMAC | refinement | | XDS | data reduction | | Aimless | data scaling | | SAWAYA | data scaling | | PHASER | phasing |
Entry History Deposition Data- Released Date: 2012-04-11
Deposition Author(s): Elkins, J.M., Vollmar, M., Wang, J., Picaud, S., Arrowsmith, C.H., Edwards, A., Bountra, C., von Delft, F., Knapp, S.
- Version 1.0: 2012-04-11
Type: Initial release
- Version 1.1: 2012-09-26
Changes: Database references, Structure summary - Version 1.2: 2018-01-24
Changes: Structure summary - Version 1.3: 2023-12-20
Changes: Data collection, Database references, Derived calculations, Other, Refinement description
|